NDC 71335-0255

NAPROXEN

Naproxen

NAPROXEN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Naproxen.

Product ID71335-0255_5d399bf3-db49-411a-91b9-b410d702a65a
NDC71335-0255
Product TypeHuman Prescription Drug
Proprietary NameNAPROXEN
Generic NameNaproxen
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-07-06
Marketing CategoryANDA / ANDA
Application NumberANDA091416
Labeler NameBryant Ranch Prepack
Substance NameNAPROXEN
Active Ingredient Strength375 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-0255-1

20 TABLET in 1 BOTTLE (71335-0255-1)
Marketing Start Date2017-10-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0255-5 [71335025505]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-6 [71335025506]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-8 [71335025508]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-1 [71335025501]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-4 [71335025504]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-7 [71335025507]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-2 [71335025502]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

NDC 71335-0255-3 [71335025503]

NAPROXEN TABLET
Marketing CategoryANDA
Application NumberANDA091416
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-31
Marketing End Date2018-08-31

Drug Details

NDC Crossover Matching brand name "NAPROXEN" or generic name "Naproxen"

NDCBrand NameGeneric Name
0054-3630NaproxenNaproxen
0093-1005NaproxenNaproxen
0093-1006NaproxenNaproxen
0143-1346NaproxenNaproxen
0143-1347NaproxenNaproxen
0143-1348NaproxenNaproxen
0143-9908NAPROXENnaproxen sodium
0143-9916NAPROXENnaproxen sodium
0179-1978NaproxenNaproxen
0440-1852NaproxenNaproxen
0440-7852NaproxenNaproxen
0615-1504NaproxenNaproxen
0615-3562NaproxenNaproxen
0615-3563NaproxenNaproxen
0615-7709NaproxenNaproxen
0615-7892NaproxenNaproxen
0615-8094NaproxenNaproxen
10544-010NaproxenNaproxen
10544-016NaproxenNaproxen
10544-019NaproxenNaproxen
10544-044NaproxenNaproxen
10544-061NaproxenNaproxen
10544-111NAPROXENNAPROXEN
10544-277NaproxenNaproxen
10544-278NaproxenNaproxen
10544-614NAPROXENnaproxen sodium
10544-920NaproxenNaproxen
10544-922NaproxenNaproxen
10544-939NaproxenNaproxen
12634-498NaproxenNaproxen
68071-3092NaproxenNaproxen
68071-4006NAPROXENNAPROXEN
68071-3029naproxennaproxen
68071-3066naproxennaproxen
68071-3387NaproxenNaproxen
68071-3345NAPROXENNAPROXEN
68071-4510NAPROXENNAPROXEN
68071-4381NAPROXENNAPROXEN
68134-201NaproxenNaproxen
68151-2894NaproxenNaproxen
68151-2609NaproxenNaproxen
68151-2895NaproxenNaproxen
68382-012NaproxenNaproxen
68382-013NaproxenNaproxen
68382-014NaproxenNaproxen
68387-800NaproxenNaproxen
68387-801NaproxenNaproxen
68387-802NaproxenNaproxen
68462-190NaproxenNaproxen
68462-189NaproxenNaproxen
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.